Pharmacokinetics of Prednisolone and Endogenous Hydrocortisone Levels in Cushingoid and Non-cushingoid Patients

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1981 Jan 1

PMID 7032949

Citations 17

Authors

F J Frey

W J Amend

F Lozada

B M Frey

N H Holford

L Z Benet

Affiliations

Soon will be listed here.

Citing Articles

Optimising prednisolone or prednisone replacement in adrenal insufficiency.

Sharma A, Lazarus K, Papadopoulou D, Prabhudev H, Tan T, Meeran K Endocr Connect. 2023; 12(8).

PMID: 37289726 PMC: 10388668. DOI: 10.1530/EC-23-0097.

Estimation of Equipotent Doses for Anti-Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor Modulator.

Almquist J, Sadiq M, Eriksson U, Hegelund Myrback T, Prothon S, Leander J CPT Pharmacometrics Syst Pharmacol. 2020; 9(8):444-455.

PMID: 32501650 PMC: 7438818. DOI: 10.1002/psp4.12536.

Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.

Bergmann T, Isbel N, Ostini R, Barraclough K, Campbell S, McWhinney B Clin Drug Investig. 2015; 35(11):743-50.

PMID: 26403249 DOI: 10.1007/s40261-015-0334-2.

Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Bergmann T, Barraclough K, Lee K, Staatz C Clin Pharmacokinet. 2012; 51(11):711-41.

PMID: 23018468 DOI: 10.1007/s40262-012-0007-8.

Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.

Bergrem H, Grottum P, Rugstad H Eur J Clin Pharmacol. 1983; 24(3):415-9.

PMID: 6861855 DOI: 10.1007/BF00610064.

References

DE MOOR P, Steeno O, Brosens I, Hendrikx A . Data on transcortin activity in human plasma as studied by gel filtration. J Clin Endocrinol Metab. 1966; 26(1):71-8. DOI: 10.1210/jcem-26-1-71. View

HULME B, James V, Rault R . Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol. 1975; 2(4):317-20. PMC: 1402595. DOI: 10.1111/j.1365-2125.1975.tb02777.x. View

Gugler R, Shoeman D, Huffman D, Cohlmia J, AZARNOFF D . Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest. 1975; 55(6):1182-9. PMC: 301871. DOI: 10.1172/JCI108035. View

. Case records of the Massachusetts General Hospital. Normal reference laboratory values. N Engl J Med. 1980; 302(1):37-48. DOI: 10.1056/NEJM198001033020108. View

Lewis G, Jusko W, Graves L, BURKE C . Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971; 2(7728):778-80. DOI: 10.1016/s0140-6736(71)92738-3. View

Gambertoglio J, Vincenti F, Feduska N, Birnbaum J, Salvatierra Jr O, Amend Jr W . Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocrinol Metab. 1980; 51(3):561-5. DOI: 10.1210/jcem-51-3-561. View

Mancini G, Carbonara A, Heremans J . Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965; 2(3):235-54. DOI: 10.1016/0019-2791(65)90004-2. View

Frey F, Frey B, Benet L . Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin Chem. 1979; 25(11):1944-7. View

McEnery P, Stempel D . Commentary: Anticonvulsant therapy and renal allograft survival. J Pediatr. 1976; 88(1):138-9. DOI: 10.1016/s0022-3476(76)80746-9. View

10.

Schalm S, Summerskill W, Go V . Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone. Gastroenterology. 1977; 72(5 Pt 1):910-3. View

11.

Petereit L, Meikle A . Effectiveness of prednisolone during phenytoin therapy. Clin Pharmacol Ther. 1977; 22(6):912-6. DOI: 10.1002/cpt1977226912. View

12.

Kozower M, Veatch L, KAPLAN M . Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab. 1974; 38(3):407-12. DOI: 10.1210/jcem-38-3-407. View

13.

Brooks S, Werk E, Ackerman S, Sullivan I, Thrasher K . Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med. 1972; 286(21):1125-8. DOI: 10.1056/NEJM197205252862103. View

14.

Uribe M, Schalm S, Summerskill W, Go V . Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. Gut. 1978; 19(12):1131-5. PMC: 1412326. DOI: 10.1136/gut.19.12.1131. View

15.

SLAUNWHITE W, LOCKIE G, Back N, Sandberg A . Inactivity in vivo of transcortin-bound cortisol. Science. 1962; 135(3508):1062-3. DOI: 10.1126/science.135.3508.1062. View

16.

Frey F, Frey B, GREITHER A, Benet L . Prednisolone clearance at steady state in dogs. J Pharmacol Exp Ther. 1980; 215(2):287-91. View

17.

Leisti S, HALLMAN N, KOSKIMIES O, Perheentupa J, Rapola J, VILSKA J . Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. Lancet. 1977; 2(8042):795-6. DOI: 10.1016/s0140-6736(77)90726-7. View

18.

Behm H, Wagner J . Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Pathol Pharmacol. 1979; 26(1):145-60. View

19.

Benet L, Galeazzi R . Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci. 1979; 68(8):1071-4. DOI: 10.1002/jps.2600680845. View

20.

Muldoon T, WESTPHAL U . Steroid-protein interactions. XV. Isolation and characterization of corticosteroid-binding globulin from human plasma. J Biol Chem. 1967; 242(23):5636-43. View